Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CON
CON logo

CON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Concentra Group Holdings Parent Inc (CON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
28.560
1 Day change
0.63%
52 Week Range
28.940
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Concentra Group Holdings Parent Inc (CON) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong analyst support with multiple Buy ratings and increasing price targets, a bullish technical setup, and no significant negative catalysts. While there are no Intellectia Proprietary Trading Signals today, the overall sentiment and data suggest a favorable entry point for long-term growth.

Technical Analysis

The technical indicators show a bullish trend. The MACD is positive and contracting, RSI indicates overbought conditions at 87.983, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 28.554) with potential upside to R2: 29.429.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
10

Positive Catalysts

  • Strong analyst support with Buy ratings and increasing price targets from Goldman Sachs, BofA, and Deutsche Bank.

  • The company is a market leader in occupational health with national scale and above-market growth potential.

  • Bullish technical indicators and strong price momentum.

Neutral/Negative Catalysts

  • RSI indicates overbought conditions, suggesting limited short-term upside.

  • No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on CON. Goldman Sachs initiated coverage with a Buy rating and $30 price target, citing strong growth potential. BofA raised its price target to $31 after a strong Q1 beat and guidance raise, while Deutsche Bank increased its target to $32. All analysts maintain Buy ratings.

Wall Street analysts forecast CON stock price to rise
4 Analyst Rating
Wall Street analysts forecast CON stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 28.380
sliders
Low
27
Averages
28.67
High
30
Current: 28.380
sliders
Low
27
Averages
28.67
High
30
Goldman Sachs
Scott Fidel
Buy
initiated
$30
AI Analysis
2026-06-05
Reason
Goldman Sachs
Scott Fidel
Price Target
$30
AI Analysis
2026-06-05
initiated
Buy
Reason
Goldman Sachs analyst Scott Fidel initiated coverage of Concentra with a Buy rating and $30 price target. The company is a the leading pure-play occupational health platform that can post above-market growth due to share gains and earnings expansion, the analyst tells investors in a research note. Goldman says Concentra has \"national scale\" and is 10-times the size of the second largest pure-play occupational health competitor.
BofA
Buy
maintain
$28 -> $31
2026-05-14
Reason
BofA
Price Target
$28 -> $31
2026-05-14
maintain
Buy
Reason
BofA raised the firm's price target on Concentra to $31 from $28 and keeps a Buy rating on the shares after having hosted Concentra's team at the BofA Healthcare Conference. The "tone was bullish coming out of a strong Q1 beat and guidance raise," says the analyst, who applies a higher multiple given increased confidence in execution.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CON
Unlock Now

People Also Watch